These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11314029)

  • 1. Cellular and viral Fos proteins are degraded by different proteolytic systems.
    Acquaviva C; Salvat C; Brockly F; Bossis G; Ferrara P; Piechaczyk M; Jariel-Encontre I
    Oncogene; 2001 Feb; 20(8):942-50. PubMed ID: 11314029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structural determinants responsible for c-Fos protein proteasomal degradation differ according to the conditions of expression.
    Ferrara P; Andermarcher E; Bossis G; Acquaviva C; Brockly F; Jariel-Encontre I; Piechaczyk M
    Oncogene; 2003 Mar; 22(10):1461-74. PubMed ID: 12629509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evasion from proteasomal degradation by mutated Fos proteins expressed from FBJ-MSV and FBR-MSV osteosarcomatogenic retroviruses.
    Acquaviva C; Bossis G; Ferrara P; Brockly F; Jariel-Encontre I; Piechaczyk M
    Biochem Pharmacol; 2002 Sep; 64(5-6):957-61. PubMed ID: 12213592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple degradation pathways for Fos family proteins.
    Acquaviva C; Bossis G; Ferrara P; Brockly F; Jariel-Encontre I; Piechaczyk M
    Ann N Y Acad Sci; 2002 Nov; 973():426-34. PubMed ID: 12485905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of cellular and viral Fos proteins.
    Acquaviva C; Ferrara P; Bossis G; Brockly F; Salvat C; Jariel-Encontre I; Piechaczyk M
    Biochimie; 2001; 83(3-4):357-62. PubMed ID: 11295497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased susceptibility to calpains of v-FosFBR but not of v-FosFBJ or v-JunASV17 retroviral proteins compared with their cellular counterparts.
    Steff AM; Carillo S; Pariat M; Piechaczyk M
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):685-92. PubMed ID: 9169601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin-independent- versus ubiquitin-dependent proteasomal degradation of the c-Fos and Fra-1 transcription factors: is there a unique answer?
    Basbous J; Jariel-Encontre I; Gomard T; Bossis G; Piechaczyk M
    Biochimie; 2008 Feb; 90(2):296-305. PubMed ID: 17825471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a C-terminal tripeptide motif involved in the control of rapid proteasomal degradation of c-Fos proto-oncoprotein during the G(0)-to-S phase transition.
    Acquaviva C; Brockly F; Ferrara P; Bossis G; Salvat C; Jariel-Encontre I; Piechaczyk M
    Oncogene; 2001 Nov; 20(51):7563-72. PubMed ID: 11709728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin-independent proteasomal degradation of Fra-1 is antagonized by Erk1/2 pathway-mediated phosphorylation of a unique C-terminal destabilizer.
    Basbous J; Chalbos D; Hipskind R; Jariel-Encontre I; Piechaczyk M
    Mol Cell Biol; 2007 Jun; 27(11):3936-50. PubMed ID: 17371847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-fos expression induces bone tumors in transgenic mice.
    Rüther U; Komitowski D; Schubert FR; Wagner EF
    Oncogene; 1989 Jul; 4(7):861-5. PubMed ID: 2547184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Fos degradation by the ubiquitin-proteasome proteolytic pathway in osteoclast progenitors.
    Ito Y; Inoue D; Kido S; Matsumoto T
    Bone; 2005 Dec; 37(6):842-9. PubMed ID: 16172035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. v-FBR-fos oncogene fails to rescue mammalian cells from growth arrest but affects the responses of human fibroblasts to heparin.
    Kolettas E; Evangelou A; Gonos ES
    Anticancer Res; 2001; 21(1A):435-44. PubMed ID: 11299775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proto-oncogene fos: an inducible multifaceted gene.
    Mitchell RL; Hanks SK; Verma IM
    Symp Fundam Cancer Res; 1986; 39():99-113. PubMed ID: 2827284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein stabilization: a common consequence of mutations in independently derived v-Myc alleles.
    Gavine PR; Neil JC; Crouch DH
    Oncogene; 1999 Dec; 18(52):7552-8. PubMed ID: 10602514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of myristylation on transrepression by FBR (Gag-Fos) protein.
    Kamata N; Holt JT
    Mol Cell Biol; 1992 Feb; 12(2):876-82. PubMed ID: 1310154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA.
    Schnappauf F; Hake SB; Camacho Carvajal MM; Bontron S; Lisowska-Grospierre B; Steimle V
    Eur J Immunol; 2003 Aug; 33(8):2337-47. PubMed ID: 12884309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a small region of the v-fos gene product that is sufficient for transforming potential and growth-stimulating activity.
    Yoshida T; Shindo Y; Ohta K; Iba H
    Oncogene Res; 1989; 5(2):79-89. PubMed ID: 2514403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2.
    Parisien JP; Lau JF; Rodriguez JJ; Sullivan BM; Moscona A; Parks GD; Lamb RA; Horvath CM
    Virology; 2001 May; 283(2):230-9. PubMed ID: 11336548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex mechanisms for c-fos and c-jun degradation.
    Jariel-Encontre I; Salvat C; Steff AM; Pariat M; Acquaviva C; Furstoss O; Piechaczyk M
    Mol Biol Rep; 1997 Mar; 24(1-2):51-6. PubMed ID: 9228281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presenilin modulates Pen-2 levels posttranslationally by protecting it from proteasomal degradation.
    Crystal AS; Morais VA; Fortna RR; Carlin D; Pierson TC; Wilson CA; Lee VM; Doms RW
    Biochemistry; 2004 Mar; 43(12):3555-63. PubMed ID: 15035625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.